Michael Kowarik
0000-0002-6512-9855
Publication & Citation Trends
Publications
0 total
Outcome of patients with COVID-19 supported by veno-venous extracorporeal membrane oxygenation with major bleeding: a single centre experience
Cited by 0
Semantic Scholar
Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study
Cited by 3
Semantic Scholar
Identification of a second glycoform of the clinically prevalent O1 antigen from Klebsiella pneumoniae OA
Cited by 12
Semantic Scholar
The development and characterization of an E. coli O25B bioconjugate vaccine OA
Cited by 21
Semantic Scholar
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate OA
Cited by 40
Semantic Scholar
The diversity of Klebsiella pneumoniae surface polysaccharides OA
Cited by 266
Semantic Scholar
An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.
Cited by 49
Semantic Scholar
Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli. OA
Cited by 49
Semantic Scholar
Research Topics
Glycosylation and Glycoproteins Research
(13)
Bacteriophages and microbial interactions
(9)
Bacterial Genetics and Biotechnology
(7)
Escherichia coli research studies
(7)
Carbohydrate Chemistry and Synthesis
(6)
Affiliations
Western University
Iowa State University
Board of the Swiss Federal Institutes of Technology
Wine Australia
ETH Zurich